shorrer doron top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active shorrer doron • jerusalem l how do i update this listing shorrer doron is based out of jerusalem whalewisdom has at least  insider transactions form  in our database for shorrer doron summary dg insider form  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from shorrer doron enter your email address below and choose submit your email cancel contact info shorrer doron  koreh pladorr st jerusalem l     business phone  sec sic codebiological products no disgnostic substances recent sec filings  filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on   filed on  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading elevate your investments try it for free doron shorrer  pluristem therapeutics inc pluristem therapeutics inc pluristem therapeutics inc company products plx products pipeline – plxpad critical limb ischemia intermittent claudication orthopedic indications pulmonary arterial hypertension women’s health pipeline – plxr hematology acute radiation syndrome clinical programs clinical development strategy critical limb ischemia cli intermittent claudication ic muscle injury acute radiation syndrome ars hematopoietic cell transplantation pulmonary arterial hypertension pah science  technology mechanism of action d manufacturing platform placenta intellectual property additional technologies preclinical programs scientific publications collaborations partnering strategy industry partners academic partners investors  media news from the media events presentations financial statements sec filing covering analysts corporate governance ir team taboolas blog doron shorrer wednesday april th by pluristemsiteadmin tweet mr doron shorrer cpa israel was chairman of the board of phoenix insurance company one of the largest insurance companies in israel and mivtachim pension benefit group the largest pension fund in israel managing  billion before assuming these positions mr shorrer held senior appointments that included arbitrator at the claims resolution tribunal for dormant accounts in switzerland economic and financial advisor commissioner of insurance and capital markets for the state of israel member of the board of directors of “nechasim” of the state of israel member of the committee for the examination of structural changes in the capital market the brodet committee general director of the ministry of transport cofounder and director of an accounting firm having three branches jerusalem telaviv haifa member of the lecture staff of the amal school chain chairman of a public committee for telecommunications and economic consultant to the ministry of energy among many areas of expertise mr shorrer formulates implements and administers business planning in the private and institutional sector additionally mr shorrer consults on economic accounting and taxation issues to a large audience ranging from private concerns to government ministries mr shorrer holds a ba in economics and accounting and an ma in business administration with a specialization in finance and banking from the hebrew university of jerusalem he is a certified public accountant isr doron shorrer  shorrer international  zoominfocom edgar filing documents for  this page uses javascript your browser either doesnt support javascript or you have it turned off to see this page as it is meant to appear please use a javascript enabled browser home  latest filings  previous page search the nextgeneration edgar system filing detail sec home » search the nextgeneration edgar system » company search » current page form   statement of changes in beneficial ownership of securities sec accession no  filing date  accepted   documents  period of report  filing date changed  document format files seq description document type size  zkhtml     zkxml     complete submission text file txt    mailing address matam advanced technology park building no  haifa l  business address matam advanced technology park building no  haifa l   pluristem therapeutics inc issuer cik  see all company filings irs no   state of incorp nv  fiscal year end sic  biological products no diagnostic substancesassistant director  mailing address  koreh pladorr st jerusalem l  business address shorrer doron reporting cik  see all company filings type   act   file no   film no  psti doron shorrer insider trades for pluristem therapeutics inc x tweet share this bulletin get news bulletins by email bulletin white house briefs reporters after spicer quits as press secretary live blog » investor alert new york markets close in market snapshot winners and losers expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close pluristem therapeutics inc nasdaq psti go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus pluristem therapeutics inc market open  real time quotes jul    pm psti quoteszigmancomposite   change   volume volume  real time quotes quoteszigmancomposite previous close     change   day low day high    week low  week high   insider activity individual doron shorrer mr doron shorrer is a director at pimi agro cleantech inc independent director at pluristem therapeutics inc and chairman  chief executive officer at shorrer international ltd he is on the board of directors at pimi agro cleantech inc omer insurance cos aig israel insurance co ltd pluristem therapeutics inc bank massad ltd massad bank ltd and pimi agro cleantech ltd mr shorrer was previously employed as chairman by israel phoenix insurance co chairman by lito group ltd and deputy chairman by opal balance investments ltd he also served on the board at b yair building corp ltd he received his undergraduate degree from the hebrew university of jerusalem and a graduate degree from the hebrew university of jerusalem transactions date shares transaction value     award at  per share      disposition at  per share      acquisition at  per share      award at  per share      award at  per share      award at  per share      award at  per share  copyright  factset research systems inc all rights reserved source factset fundamentals officers and executives mr zami aberman chairman  cochief executive officer mr yaky yanay president cochief executive officer  director mr erez egozi chief financial officer  treasurer dr esther lukasiewiczhagai vice presidentclinical  medical affairs dr racheli ofir vice presidentresearch  intellectual property dr hillit mannor shachar vice presidentbusiness development dr moria kwiat director ms hava klemperer meretzki director mr isaac braun director mr mark s germain director mr efrat kaduri managerinvestor  public relations ms karine kleinhaus vice presidentnorth america division  ir contact ms efrat livnehadass vice presidenthuman resources mr doron shorrer independent director mr israel benyoram independent director mr nachum rosman independent director trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york open marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pgold logs highest finish in a month up over  for the week pmicrosoft is challenging amazon for cloud throne pam i entitled to a spousal benefit pwhite house briefs reporters after spicer quits as press secretary live blog pnot even free money can make some people go to the gym p seriously inappropriate things you should never ever say to a coworker pwant to buy happiness splurge on these  things pnote to parents this social network was rated the worst for teenage cyberbullying ppreserving a fruitful retirement pthis is the deadliest time of your life to put on weight pthe dark side of cruises p reasons why millennials can’t have nice things or save any money pwhat eleanor roosevelt and helen gurley brown ate — and what we can learn from it p moneymaking lessons from the richest man who ever lived p‘property brothers’ is inspiring homeowners to remodel — but creating fictional expectations about how much it costs pthis week’s retirement news phollywood is using social causes to sell movie tickets pgold marks highest settlement in a month up over  for the week pspicer says in a tweet hell continue in job through august pgold prices end at highest level in a month up over  for the week loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  doron shorer   decypha sign in  welcome guest regions gcc  levant  mena  north africa gcc bahrain  kuwait  oman  qatar  saudi arabia  united arab emirates levant iraq  jordan  lebanon  palestine north africa egypt  libya  morocco  tunisia others iran  turkey  united kingdom  united states advanced search news markets companies research funds fixed income money markets commodities fx economics analysis more sign in membership customize your decypha logout welcome decypha alerts home people profiles people profile doron shorer profile full name doron shorer country biography mr shorrer became a director of the company in october  mr shorrer was one of the company’s founders and served as its first chairman until  designations date designation entity entity description country  pluristem therapeutic   check all the individuals in check the list request a trial title select mr mrs ms miss dr prof first name last name job title select asset managers corporate banks investment managers wealth managers consultants  advisors legal practioners academics hedge funds private equity analysts traders equity research analysts phone company email country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe comments required fields   submit already registered login attempt was not successful please try again username email password enter characters   login forget your password by job title asset managers  corporate banks  investment managers  wealth managers  consultants  advisors  legal practitioners  academics  hedge funds  private equity analysts  traders  equity research analysts by scope equity  fixed income  funds  excel  analytical tools  markets  prices  money market  news  industry  ipos  mergers  acquisitions  commodities  economics covered countries and exchanges add your company   add yourself   terms and conditions   privacy policy   about directfn copyright  directfn all rights reserved data not available login login attempt was not successful please try again username email password enter characters forget your password back to top support  feedback ask for free trial request a trial title mr mrs ms miss dr prof first name last name email phone promo code country select afganistan albania algeria american samoa andorra angola anguilla antarctica antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana bouvet island brazil british indian ocean territory brunei bulgaria burkina faso burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island cocos keeling islands colombia comoros congo cook islands costa rica cote divoire ivory coast croatia hrvatska cuba curacao cyprus czech republic czechoslovakia former denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands malvinas faroe islands fiji finland france france metropolitan french guiana french polynesia french southern territories gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guernsey guinea guineabissau guyana haiti heard and mcdonald islands honduras hong kong hungary iceland india indonesia iran iraq ireland isle of man israel italy jamaica japan jersey jordan kazakhstan kenya kiribati kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles neutral zone new caledonia new zealand aotearoa nicaragua niger nigeria niue norfolk island north korea northern mariana islands norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines pitcairn poland portugal puerto rico qatar reunion romania russia rwanda s georgia and s sandwich isls saint kitts and nevis saint lucia saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovak republic slovenia solomon islands somalia south africa south korea south sudan spain sri lanka st helena st pierre and miquelon sudan suriname svalbard and jan mayen islands swaziland sweden switzerland syria taiwan tajikistan tanzania thailand togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu us minor outlying islands ussr former uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city state holy see venezuela vietnam virgin islands british virgin islands us wallis and futuna islands western sahara yemen yugoslavia zaire zambia zimbabwe company job title select academics asset managers consultants  advisors corporate banks equity research analysts hedge funds investment managers legal practioners private equity analysts traders wealth managers comments required fields   submit contact us hello please use the below form for product support  feedback name   email  phone number   preferred contact method  email phone technical support x     slhopsdirectfnnet your account manager is   get a decypha membership to view this content get a decypha membership get the membership of decypha premium package to access more exciting features including advanced analytical tools and the pro  package pro  is designed keeping active investors in mind and offers a flexible framework to view information and do analysis the way you desire all you need to access these valuable features is to click on the get a membership button and submit your details to our sales team upgrade your membership account is not entitled to view this information please contact your account manager to upgrade your membership email  supportdecyphacom register to view this content decypha free registration register free with decypha and get access to realtime price information and many other features including technical scanner fundamental screener etc just click the registration button submit your details and get registered for free the company  pluristem therapeutics inc pluristem therapeutics inc pluristem therapeutics inc company products plx products pipeline – plxpad critical limb ischemia intermittent claudication orthopedic indications pulmonary arterial hypertension women’s health pipeline – plxr hematology acute radiation syndrome clinical programs clinical development strategy critical limb ischemia cli intermittent claudication ic muscle injury acute radiation syndrome ars hematopoietic cell transplantation pulmonary arterial hypertension pah science  technology mechanism of action d manufacturing platform placenta intellectual property additional technologies preclinical programs scientific publications collaborations partnering strategy industry partners academic partners investors  media news from the media events presentations financial statements sec filing covering analysts corporate governance ir team pluristem therapeutics inc is a clinicalstage biotherapy company using placental cells and a unique proprietary threedimensional d technology platform to develop cell therapies for conditions such as inflammation ischemia hematological disorders or exposure to radiation our vision our vision is to leverage our advanced technology and our position as a global leader in cell therapy to develop and manufacture highly effective cell products that will heal patients around the world our strategy our strategy is to develop powerful cell therapies that can be successfully commercialized to reach patients who need innovative treatment options we develop placentaderived “offtheshelf” products that do not need genetic or tissue matching prior to administration and could be delivered in almost any clinical setting we design distinct cell products to target a variety of indications and anticipate that a pipeline of differentiated products and indications will allow us to target large global markets we explore new partnerships to advance our clinical development programs while maintaining our strong commitment to current corporate academic and government collaborations management team zami aberman chairman  coceo zami aberman joined pluristem in september  and redirected the companys strategy towards cellular therapeutics to become one of the global leaders in the industry mr abermans vision to use the maternal portion of the placenta as a cell source for pluristem’s products combined with pluristems d culturing technology led to the development of the companys unique therapies in  the world stem cells regenerative medicine congress ranked mr aberman as one of the  most influential people in the stem cells space prior to pluristem mr aberman had a  year career as a senior executive in the hightech industry with multiple companies in israel the us europe japan and korea previous roles include chairman of vlscom ltd a private company specializing in video compression for hdtv and video over ip director of ori software ltd a company involved in data management president and ceo of elbit vision systems evsnfob which supplies inspection systems for the microelectronics industry president and ceo of netect ltd a company specializing in the field of internet security software cofounder president and ceo of associative computing ltd which developed an associative parallel processor for realtime video processing chairman of display inspection systems inc a company specializing in laser based inspection machines and president and ceo of robomatix technologies ltd rbmxfob in addition to his current role at pluristem mr aberman serves as the chairman of rose hitech ltd a private investment company in  mr aberman was awarded the rothschild prize for excellence in his field from the president of the state of israel mr aberman holds a bsc in mechanical engineering from ben gurion university in israel yaky yanay coceo and president yaky yanay was appointed as our president from february  and as our coceo from march  mr yanay served as our chief financial officer from november  until february  and from february  until march  he also served as our chief operating officer from february  until march  until february  he also served as our secretary since november  and executive vice president since march  before joining pluristem mr yanay was the chief financial officer of elbit vision systems ltd a public company prior to that mr yanay served as manager of audit groups of the technology sector at ernst  young israel mr yanay is cochairman of israel advanced technology industries iati the largest umbrella organization representing israel’s high tech and life science industries yanay is representing israel’s life sciences industry and has served on the board of directors of iati for the past four years mr yanay also founded and served as chairman of the “the life science forum” mr yanay holds a bachelor’s degree with honors in business administration and accounting and is a certified public accountant in israel efrat livnehadass vp human resources efrat livnehadass joined pluristem in  and is responsible for all aspects of human resources management including recruitment professional training and wellbeing prior to joining pluristem and during the years  ms livnehadass held the position of human resources manager at elbit vision systems a company engaged in automatic optical inspection located in yokneam israel while holding that position she was involved in some major challenges and change processes which the company was going through including managing hr in a small yet global public company ms livnehadass holds an executive ma for human resources managers from the department of labor studies telaviv university and a bsw degree from the haifa university majoring in public healthcare services hillit mannor shachar md vp business development hillit mannor shachar md joined pluristem in october  as vp of business development prior to joining pluristem dr shachar had over ten years experience in both business development and corporate development having worked and consulted at companies including west pharmaceutical services nektar therapeutics orex computer radiography acquired by kodak and transpharma medical dr shachar worked at apax partners as a healthcare associate and at deloitte israel as a consultant in their life science practice dr shachar graduated from northwestern universitys honors program in medical education and holds a ba and md from there in addition she holds a mba from kellogg recanati executive program and an msfs from georgetown university erez egozi cfo mr erez egozi was appointed chief financial officer in march  and as secretary in september  prior to his appointment as cfo mr egozi was our vice president of finance from march  until march  before joining pluristem from  to  mr egozi held several senior financial positions at verint systems inc nasdaqvrnt including as senior director of finance  worldwide finance controller of verints communications and cyber intelligence solutions division from  to  mr egozi held several financial positions at intel corporation nasdaqintc from  to  mr egozi served as an auditor in the high tech technology sector at deloitte  touche  mr egozi holds a bachelors degree in economics and accounting from beersheva university and a ma degree in law from barilan university and is a certified public accountant in israel esther lukasiewicz hagai md phd vp clinical  medical affairs dr lukasiewiczhagai has twelve years experience in drug development she joins pluristem from teva global rd where she was director clinical program leader leading the global clinical development of multiple biosimilars and innovative drugs in various oncologic and neuropsychiatric indications she previously worked at gertner institute for epidemiology and health policy research sheba medical center tel hashomer where she was responsible of multiple national and usisraeli clinical trials in orthopedic and hematooncologic indications dr lukasiewiczhagai holds a md and a medical residency in public health and social medicine from neckerenfants malades paris v school of medicine in addition she holds a master of methodology and statistics in clinical research and a m med sc in biostatistics and epidemiology from paris xi as well as a phd in biostatistics from barilan university sagi moran mba vp operations sagi moran joined pluristem in june  as vp of operations prior to joining pluristem mr moran served as the cto for laser medical device startup axonogen ltd and as coo for novoxel ltd mr moran established a medical division for qualitest group ltd the largest engineering and testing services group for the medical industry in israel the division provides services for pharmaceutical and medical companies such as teva philips healthcare ge ultrashape given imaging and others prior to that mr moran served for  years in lumenis ltd in key global managerial position in rd and operations mr moran holds a master of business administration mba from recanati executive mba program at telaviv university and a bachelor’s degree in information systems from haifa university orly amiran vp quality assurance orly amiran holds a master degree in quality assurance from the technion and a bsc in pharmacy from the hebrew university she has worked in the pharmaceutical industry since  and has extensive experience in quality assurance management in global companies which market drugs to the european market and to north america prior to joining pluristem orly held the positions of quality assurance manager at teva and compliance manager at taro she played a central role in successful regulatory agencies inspections in both positions ms orly amiran brings with her to pluristem a vast experience and knowledge on gmp quality regulations and the corresponding industry best practices racheli ofir phd ma law vp research  intellectual property racheli ofir joined pluristem in  serves as vice president of research and intellectual property the research department examines the various cells developed by the company the properties of those cells and their mechanisms of action by using molecular methods and animal models to test the safety and efficacy the ip department is responsible for intellectual property strategy development as well as the research that supports the ip dr ofir is responsible for leading projects involving the characterization of plx cells pluristems leading placenta derived cell product candidate including evaluating the biological activity of the cells in invitro and animal studies she is responsible for the studies which determines the safety profile and pharmacokinetics of plx cells in addition she is in charge of all preclinical aspects of the plx regulatory process and for the communications with the relevant regulatory authorities fda ema and pei dr ofir is also responsible for applying and prosecuting over ten patent families filed worldwide a coinventor on five patent applications and the coauthor of numerous peer reviewed articles dr ofir earned her phd from the technion israel institute of technology where she investigated telomeric position effects on gene expression and dna replication in human cells she did her postdoctoral fellowship at the technion in molecular embryology investigating genes involved in early development of vertebrates nervous system dr ofir has extensive research experience in molecular cell biology embryology and cytogenetics as well as broad professional experience in the field of human cell therapy lior raviv vp development lior raviv joined pluristem in  and currently serves as vice president of development prior to that mr raviv served as process development engineer and projects manager  product development team leader at pluristem prior to joining pluristem and during the years  mr raviv held the position of rd analytical researcher at teva pharmaceutical industries mr raviv holds a mmedsec in pharmacology from the ben gurion university and a bsc in biotechnology engineering from the ben gurion university karine kleinhaus md mph divisional vp north america karine kleinhaus md mph is divisional vice president north america at pluristem therapeutics she has worked with multiple public and private biotechnology companies and prior to that she was an assistant professor in the departments of obstetrics and gynecology and psychiatry at the nyu school of medicine at nyu dr kleinhaus conducted medical research funded under a multiyear nih grant she published more than  papers in leading peerreviewed journals such as the annals of the new york academy of science american journal of medical genetics and the american journal of epidemiology before that dr kleinhaus practiced obstetrics and then completed two fellowships at columbia university dr kleinhaus received her medical degree from tel aviv university earned a master of public health from columbia’s mailman school of public health and a bachelor’s degree cum laude from princeton university board zami aberman mr zami aberman joined pluristem in september  and redirected the companys strategy towards cellular therapeutics to become one of the global leaders in the industry mr abermans vision to use the maternal portion of the placenta as a cell source for pluristem’s products combined with pluristems d culturing technology led to the development of the companys unique therapies in  the world stem cells regenerative medicine congress ranked mr aberman as one of the  most influential people in the stem cells space prior to pluristem mr aberman had a  year career as a senior executive in the hightech industry with multiple companies in israel the us europe japan and korea previous roles include chairman of vlscom ltd a private company specializing in video compression for hdtv and video over ip director of ori software ltd a company involved in data management president and ceo of elbit vision systems evsnfob which supplies inspection systems for the microelectronics industry president and ceo of netect ltd a company specializing in the field of internet security software cofounder president and ceo of associative computing ltd which developed an associative parallel processor for realtime video processing chairman of display inspection systems inc a company specializing in laser based inspection machines and president and ceo of robomatix technologies ltd rbmxfob in addition to his current role at pluristem mr aberman serves as the chairman of rose hitech ltd a private investment company in  mr aberman was awarded the rothschild prize for excellence in his field from the president of the state of israel mr aberman holds a bsc in mechanical engineering from ben gurion university in israel yaky yanay mr yaky yanay was appointed as pluristem’s president in february  and as coceo from march  mr yanay served as our chief financial officer from november  until february  and from february  until march  he also served as our chief operating officer from february  until march  until february  he also served as our secretary since november  and executive vice president since march  before joining pluristem mr yanay was the chief financial officer of elbit vision systems ltd a public company prior to that mr yanay served as manager of audit groups of the technology sector at ernst  young israel mr yanay is cochairman of israel advanced technology industries iati the largest umbrella organization representing israel’s high tech and life science industries yanay is representing israel’s life sciences industry and has served on the board of directors of iati for the past four years mr yanay also founded and served as chairman of the “the life science forum” mr yanay holds a bachelor’s degree with honors in business administration and accounting and is a certified public accountant in israel mark germain mr mark germain has served as a director on the board of directors since may   for more than the past five years mr germain has been a merchant banker serving primarily the biotech and life sciences industries he has been involved as a founder director chairman of the board andor investor in over twenty companies in the biotech field and assisted many of them in arranging corporate partnerships acquiring technology entering into mergers and acquisitions and executing financings and going public transactions he graduated new york university school of law in  order of the coif and was a partner in a new york law firm practicing corporate and securities law from  to  he served in senior executive capacities including as president of a public company that was sold in  at which time he entered the biotech field in addition to being cochairman at pluristem mr germain is a director of the following publicly traded companies wellford real properties inc stem cell innovations inc and collexis holdings inc he is also a cofounder and director of a number of private companies in the biotechnology field hava klemperer meretzki mrs hava klemperer meretzki adv is a partner in the law firm of bennoun meretzki in haifa israel she specializes in civil trade and labor law and is presently vicechairman for the national council of the israel bar association she previously was a director of the israel electric company ms meretzki received a bachelors degree in law from the hebrew university in  and in  was admitted to the israel bar association doron shorrer mr doron shorrer cpa israel was chairman of the board of phoenix insurance company one of the largest insurance companies in israel and mivtachim pension benefit group the largest pension fund in israel managing  billion before assuming these positions mr shorrer held senior appointments that included arbitrator at the claims resolution tribunal for dormant accounts in switzerland economic and financial advisor commissioner of insurance and capital markets for the state of israel member of the board of directors of nechasim of the state of israel member of the committee for the examination of structural changes in the capital market the brodet committee general director of the ministry of transport cofounder and director of an accounting firm having three branches jerusalem telaviv haifa member of the lecture staff of the amal school chain chairman of a public committee for telecommunications and economic consultant to the ministry of energy among many areas of expertise mr shorrer formulates implements and administers business planning in the private and institutional sector additionally mr shorrer consults on economic accounting and taxation issues to a large audience ranging from private concerns to government ministries mr shorrer holds a ba in economics and accounting and an ma in business administration with a specialization in finance and banking from the hebrew university of jerusalem he is a certified public accountant isr isaac braun mr isaac braun was appointed a director of pluristem on july   mr braun is a business veteran with entrepreneurial industrial and manufacturing experience he has been a cofounder and board member of several hitech startups in the areas of ecommerce security messaging search engines and biotechnology mr braun advises private companies on raising financing and business development israel ben yoram mr israel benyoram was appointed a director of pluristem on january   mr benyoram has been a director and partner in the accounting firm of mor benyoram and partners in israel from  to the present this accounting firm currently employs over  employees in the field of auditing consulting and associated projects since  mr benyoram has served as a shareholder and the head director of mor benyoram ltd a private company in israel in parallel with the operation of the mor benyoram and partners accounting firm this company provides management services economic consulting services and other professional services to businesses mr benyoram received a ba in accounting from the university of tel aviv an ma in economics from the hebrew university of jerusalem an llb and an mba from tel aviv university and an llm from barilan university nachum rosman mr nachum rosman is an expert in finance management and organization he has held chief executive and cfo positions in israel usa and england he has operated in hightech global companies in software and business in these jobs he was responsible for finance management fundraising acquisitions technology sales preparation of financial reports for due diligences etc mr rosman serves as a consultant to startup companies in financing strategy and reorganization he serves as the ceo of multiview ltd a company he cofounded in  he serves as a director at zoomix data mastering and knolan mr rosman was a director actively involved in the sale of new dimension ltd to bmc inc for   million prior to that he held a coceo position in rts ltd virinet ltd where he participated in the ipo on nasdaq moria kwiat dr moria kwiat is a research fellow in the department of materials and nanosciences faculty of chemistry at tel aviv university during her studies she has gained a broad scientific experience in interdisciplinary fields and currently she is working on the development of a new generation of biosensors based on nanomaterials mrs kwiat holds a bsc and msc in biotechnology from the department of molecular microbiology and biotechnology at tel aviv university and a phd in nanobiotechnology from the faculty of exact sciences at tel aviv university pluristem therapeutics inc pstiph company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile pluristem therapeutics inc pstiph related topics stocksstock screenerhealthcarebiotechnology  medical research overview news key developments people charts financials analysts research pulse pstiph on philadelphia stock exchange usd  jul  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description pluristem therapeutics inc incorporated on may   is a developer of placentabased cell therapy product candidates for the treatment of multiple ischemic inflammatory and hematologic conditions the companys lead indications are critical limb ischemia cli recovery after surgery for femoral neck fracture and acute radiation syndrome the companys operations are focused on the research development clinical trials and manufacturing of cell therapeutics and related technologies the companys products include plxpad and plx r the companys plx cells are adherent stromal cells ascs that are expanded using a three dimensional d process the system utilizes a synthetic scaffold to create an artificial d environment where placentalderived stromal cells can grow the companys plx products are administered using a standard needle and syringe the companys plx products are in clinicalstage development for multiple indications such as cardiovascular orthopedic pulmonary and womens health diseasesthe company is investigating using plxpad cells for treatments for various stages of peripheral arterial disease from earlystage intermittent claudication ic to advanced cli as of june   the company completed two phase i safetydosefinding clinical trials for cli one in the united states and one in germany the company is conducting a phase iii randomized doubleblind placebo controlled study to assess the safety and efficacy of intramuscular injections of allogeneic plx pad cells for the regeneration of injured gluteal musculature after total hip replacement in germany the company focuses on pursuing the development of plxr in the treatment of recovery following hematopoietic cell transplantation hct as of june   the company had conducted several invivo studies for the evaluation of plxr for the treatment of acute radiation syndrome arsthe company competes with athersys inc capricor therapeutics inc celgene corporation reneuron group plc tigenix nv sanbio inc healios kk cytori therapeutics green cross cell corp and mesoblast ltd » full overview of pstiph company address pluristem therapeutics inc matam advanced technology parkbuilding no haifa      p f  company web links home page officers  directors name compensation yaky yanay  zalman aberman  erez egozi  doron shorrer  moria kwiat  » more officers  directors pluristem therapeutics inc news briefpluristem advances its limb ischemia study targeting initiation at  active sites by the year end jul   briefpluristem therapeutics files for mixed shelf of up to  mln  sec filing jun   briefinnovation medical management scraps plan to invest in israels pluristem therapeutics jun   briefpluristem provides shareholder update on corporate clinical developments may   briefpluristem provides results from acute radiation syndrome preclinical study may   » more pstiph news related topics stocksstock screenerhealthcarebiotechnology  medical research